Evidence-based Guideline Update: Medical Treatment of Infantile Spasms
Neurol 78:1974-1980, Go, C.Y.,et al, 2012
Vigabatrin Improves Paroxysmal Dystonia in Succinic Semialdehyde Dehydrogenase Deficiency
Neurol 68:1320-1321, Leuzzi,V.,et al, 2007
The United Kingdom Infantile Spasms Study Comparing Vigabatrin with Prednisolone or Tetracosactide at 14 Days: A Multicentre, Randomised Controlled Trial
Lancet 364:1773-1778, Lux,A.L.,et al, 2004
Visual Impairment in Children with Epilepsy Treated with Vigabatrin
Ann Neurol 48:60-64, Gross-Tsur,V. et al, 2000
Visual Function Loss From Vigabatrin
Neurol 55:40-45, Johnson,M.A. et al, 2000
Focal Lesion in the Splenium of the Corpus Callosum in Epileptic Patients:Antiepileptic Drug Toxicity
AJNR 20:125-129,131, Kim,S.S.,et al, 1999
ACTH Versus Vigabatrin Therapy in Infantile Spasms:A Retrospective Study
Neurol 52:1691-1694,1537, Cossette,P.,et al, 1999
Open Comparative Long-Term Study of Vigabatrin vs Carbamazepine in Newly Diagnosed Partial Seizures in Children
Arch Neurol 56:605-607, Zamponi,N.&Cardinali,C., 1999
Visual Field Constriction in Children Treated with Vigabatrin
Neurol 52:1713-1714,1537, Vanhatalo,S.&Paakkonen,L., 1999
Safety and Efficacy of Vigabatrin and Carbamazepine in Newly Diagnosed epilepsy:A Multicentre Randomised Double-Blind Study
Lancet 354:13-19, Chadwick,D., 1999
Vigabatrin, a Gabaergic Antiepileptic Drug, Causes Concentric Visual Field Defects
Neurol 53:922-926, Kalviainen,R.,et al, 1999
Psychiatric Adverse Events During Vigabatrin Therapy
Neurol 53:1503-1511, Levinson,D.F.&Devinsky,O., 1999
Visual Field Defects Associated with Vigabatrin Therapy
JNNP 67:716-722, Lawden,M.C.,et al, 1999
Vigabatrin-Associated Retinal Cone System Dysfunction, Electroretinogram & Ophthalmol Findings
Neurol 50:614-618, Krauss,G.L.,et al, 1998
Acute Encephalopathy Associated with Vigabatrin Monotherapy in Patients with Mild Renal Failure
Neurol 51:314-315, Ifergane,G.,et al, 1998
New Antiepileptic Drugs
Arch Neurol 55:1181-1183, Bourgeois,B.F.D., 1998
Severe Persistent Visual Field Constriction Associated with Vigabatrin
BMJ 14:180-181, Eke,T.,et al, 1997
Improvement of Stiff-Man Syndrome with Vigabatrin
Neurol 48:1133-1134, Prevett,M.C.,et al, 1997
New Antiepileptic Drugs
NEJM 334:1583-1590, Dichter,M.A.&Brodie,M.J., 1996
New Antiepileptic Drugs:A Systematic Review of Their Efficacy and Tolerability
BMJ 313:1169-1174, 1157, 1158996., Marson,A.G.,et al, 1996
Long Term Use of Lamotrigine & Vigabatrin in Severe Refractory Epilepsy:Audit of Outcome
BMJ 313:1184-1185, 11571996., Walker,M.C.,et al, 1996
Rational Polypharmacy in the Treatment of Epilepsy
(Ed) , Neurol (suppl) 45:S1-S38., Wilder,B.J., 1995
Vigabatrin vs Carbamazepine Monotherapy in Patients with Newly Diagnosed Epilepsy
Arch Neurol 52:989-996, Kalviainen,R.,et al, 1995
New Antiepileptic Drugs
Neurol 44:787-795, Harden,C.L., 1994
Vigabatrin and Lamotrigine in Refractory Epilepsy
JNNP 57:921-924, Stolarek,I.,et al, 1994
Effects of Vigabatrin on Partial Seizures and Cognitive Function
JNNP 57:1057-1063, Grunewald,R.A.,et al, 1994
Evaluation of the Effects of Vigabatrin on Cognitive Abilities and Quality of Life in Epilepsy
Neurol 43:2501-2507, Dodrill,C.B.,et al, 1993
Vigabatrin in the Treatment of Infantile Spasms
Neuropediatrics 24:230-231, Vles,J.S.H.,et al, 1993
Multicenter Long-Term Safety and Efficacy Study of Vigabatrin for Refractory Complex Partial Seizures:An Update
Neurol 41:363-364, Browne,T.R.,et al, 1991
Vigabatrin and Psychosis
JNNP 54:435-439, Sander,J.W.A.S.,et al, 1991
Vigabatrin
BMJ 300:277-278, 1990, Reynolds,E.H., 1990
Vigabatrin
Editorial, Lancet 1:532-5331989., , 1989
Vigabatrin in the Treatment of Epilepsy:A Long-Term Follow-Up Study
JNNP 52:467-471, Tartara,A.,et al, 1989
Double-Blind Study of Vigabatrin in the Treatment of Drug-Resistant Epilepsy
Arch Neurol 44:907-910, Tassinari,C.A.,et al, 1987